Zymeworks Inc (NAS:ZYME)
$ 9.08 -0.3 (-3.2%) Market Cap: 643.77 Mil Enterprise Value: 343.39 Mil PE Ratio: 0 PB Ratio: 1.47 GF Score: 78/100

Q4 2022 Zymeworks Inc Earnings Call Transcript

Mar 07, 2023 / 09:30PM GMT
Release Date Price: $7.96 (+0.13%)
Operator

Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Zymeworks Fourth Quarter and Full Year 2022 Results Conference Call. (Operator Instructions)

At this time, I would like to turn the conference over to Mr. Jack Spinks of Investor Relations for Zymeworks. Sir, you may begin.

Jack W. Spinks
Zymeworks Inc. - Associate Director of IR

Good afternoon, and welcome, everyone. My name is Jack Spinks, Head of Investor Relations here at Zymeworks. Today, we will discuss our fourth quarter and full year 2022 financial results as well as provide an update to our ongoing business.

Before we begin, I'd like to remind you that we will be making a number of forward-looking statements during this call, including, without limitation, those forward-looking statements identified in our presentation slides and the accompanying oral commentary. Forward-looking statements are based upon our current expectations and various assumptions and are subject to the usual risks and uncertainties associated with companies in our industry and at our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot